89-133-744

APOE Rabbit anti-Human, Polyclonal Antibody, Abnova™

Manufacturer: Abnova Corporation

Select a Size

Pack Size SKU Availability Price
Each of 1 89-133-744-Each-of-1 In Stock ₹ 70,221.00

89-133-744 - Each of 1

₹ 70,221.00

In Stock

Quantity

1

Base Price: ₹ 70,221.00

GST (18%): ₹ 12,639.78

Total Price: ₹ 82,860.78

Antigen

APOE

Classification

Polyclonal

Description

Rabbit polyclonal antibody raised against a recombinant APOE.

Formulation

In PBS, pH 7.2 (30% glycerol, 0.5mg/mL BSA, 0.01% thimerosal)

Gene Alias

AD2/LPG/MGC1571/apoprotein

Host Species

Rabbit

Quantity

100 μg

Primary or Secondary

Primary

Test Specificity

This antibody recognizes ∼34 KDa of human APOE3.

Content And Storage

Store at -20°C. For long term storage store at -80°C.Aliquot to avoid repeated freezing and thawing.

Applications

Western Blot

Conjugate

Unconjugated

Dilution

Western Blot (0.5-4 ug/mL) The optimal working dilution should be determined by the end user.

Gene

APOE

Gene Symbols

APOE

Immunogen

Recombinant protein corresponding to human APOE.

Regulatory Status

RUO

Gene ID (Entrez)

348

Target Species

Human

Form

Liquid

Related Products

Img

Abnova Corporation

89-119-601

--

Img

Abnova Corporation

89-133-742

--

Img

Abnova Corporation

89-133-741

--

Img

Abnova Corporation

89-133-827

--

Img

Abnova Corporation

89-133-747

--

Img

Abnova Corporation

89-133-771

--

Img

Abnova Corporation

89-133-737

--

Img

Abnova Corporation

89-119-575

--

Description

  • Chylomicron remnants and very low density lipoprotein (VLDL) remnants are rapidly removed from the circulation by receptor-mediated endocytosis in the liver
  • Apolipoprotein E, a main apoprotein of the chylomicron, binds to a specific receptor on liver cells and peripheral cells
  • ApoE is essential for the normal catabolism of triglyceride-rich lipoprotein constituents
  • The APOE gene is mapped to chromosome 19 in a cluster with APOC1 and APOC2
  • Defects in apolipoprotein E result in familial dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III), in which increased plasma cholesterol and triglycerides are the consequence of impaired clearance of chylomicron and VLDL remnants
  • [provided by RefSeq